Targeted Delivery of Geraniol via Hyaluronic Acid-Conjugation Enhances Its Anti-Tumor Activity Against Prostate Cancer

References

• Chhikara BS, Parang K. Global Cancer Statistics 2022: the trends projection analysis. Chem Biol Lett. 2023;10(1):451.
   Web of Science ®Google Scholar
• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–590. doi:10.1097/CM9.0000000000002108
   PubMed Web of Science ®Google Scholar
• Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomed. 2018;13:3921–3935. doi:10.2147/IJN.S165210
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–146. doi:10.1016/j.jconrel.2010.08.027
   PubMed Web of Science ®Google Scholar
• Wang CY, Yamada H, Morton KC, Zukowski K, Lee MS, King CM. Induction of repair synthesis of DNA in mammary and urinary bladder epithelial cells by N-hydroxy derivatives of carcinogenic arylamines. Cancer Res. 1988;48(15):4227–4232.
   PubMed Web of Science ®Google Scholar
• Niu B, Liao K, Zhou Y, et al. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110. doi:10.1016/j.biomaterials.2021.121110
   PubMed Web of Science ®Google Scholar
• Zou L, Liu X, Li J, et al. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Theranostics. 2021;11(9):4171–4186. doi:10.7150/thno.42260
   PubMed Web of Science ®Google Scholar
• Li J, Burgess DJ. Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment. Acta Pharm Sin B. 2020;10(11):2110–2124. doi:10.1016/j.apsb.2020.05.008
   PubMed Web of Science ®Google Scholar
• Yang S, Gao H. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res. 2017;126:97–108. doi:10.1016/j.phrs.2017.05.004
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang T, Duan S, Davies NM, Forrest ML. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy. Nanomedicine. 2014;10(6):1221–1230. doi:10.1016/j.nano.2014.02.015
   PubMed Web of Science ®Google Scholar
• Mohammed M, Devnarain N, Elhassan E, Govender T. Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(4):e1799. doi:10.1002/wnan.1799
   PubMed Web of Science ®Google Scholar
• Hassn Mesrati M, Syafruddin SE, Mohtar MA, Syahir A. CD44: a Multifunctional Mediator of Cancer Progression. Biomolecules. 2021;11(12):1850. doi:10.3390/biom11121850
   PubMed Web of Science ®Google Scholar
• Morath I, Hartmann TN, Orian-Rousseau V. CD44: more than a mere stem cell marker. Int J Biochem Cell Biol. 2016;81(Pt A):166–173. doi:10.1016/j.biocel.2016.09.009
   PubMedGoogle Scholar
• Li W, Qian L, Lin J, et al. CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4. Oncotarget. 2017;8(39):65143–65151. doi:10.18632/oncotarget.17821
   PubMedGoogle Scholar
• Korski K, Malicka-Durczak A, Breborowicz J. Expression of stem cell marker CD44 in prostate cancer biopsies predicts cancer grade in radical prostatectomy specimens. Pol J Pathol. 2014;65(4):291–295. doi:10.5114/pjp.2014.48190
   PubMed Web of Science ®Google Scholar
• Ali Abdalla YO, Subramaniam B, Nyamathulla S, et al. Natural Products for Cancer Therapy: a Review of Their Mechanism of Actions and Toxicity in the Past Decade. J Trop Med. 2022;2022:5794350. doi:10.1155/2022/5794350
   PubMed Web of Science ®Google Scholar
• Fatima K, Wani ZA, Meena A, Luqman S. Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells. Phytother Res. 2021;35(7):3861–3874. doi:10.1002/ptr.7094
   PubMed Web of Science ®Google Scholar
• Maczka W, Winska K, Grabarczyk M. One Hundred Faces of Geraniol. Molecules. 2020;25(14):3303. doi:10.3390/molecules25143303
   PubMed Web of Science ®Google Scholar
• Choi HS, Song HS, Ukeda H, Sawamura M. Radical-scavenging activities of citrus essential oils and their components: detection using 1,1-diphenyl-2-picrylhydrazyl. J Agric Food Chem. 2000;48(9):4156–4161. doi:10.1021/jf000227d
   PubMed Web of Science ®Google Scholar
• El-Ganainy SO, Shehata AM, El-Mallah A, Abdallah D, Mohy El-Din MM. Geraniol suppresses tumour growth and enhances chemosensitivity of 5-fluorouracil on breast carcinoma in mice: involvement of miR-21/PTEN signalling. J Pharm Pharmacol. 2023;75(8):1130–1139. doi:10.1093/jpp/rgad060
   PubMed Web of Science ®Google Scholar
• Galle M, Crespo R, Kladniew BR, Villegas SM, Polo M, de Bravo MG. Suppression by geraniol of the growth of A549 human lung adenocarcinoma cells and inhibition of the mevalonate pathway in culture and in vivo: potential use in cancer chemotherapy. Nutr Cancer. 2014;66(5):888–895. doi:10.1080/01635581.2014.916320
   PubMed Web of Science ®Google Scholar
• Carnesecchi S, Bras-Goncalves R, Bradaia A, et al. Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Cancer Lett. 2004;215(1):53–59. doi:10.1016/j.canlet.2004.06.019
   PubMed Web of Science ®Google Scholar
• Jin X, Sun J, Miao X, Liu G, Zhong D. Inhibitory effect of geraniol in combination with gemcitabine on proliferation of BXPC-3 human pancreatic cancer cells. J Int Med Res. 2013;41(4):993–1001. doi:10.1177/0300060513480919
   PubMed Web of Science ®Google Scholar
• Chaudhary SC, Siddiqui MS, Athar M, Alam MS. Geraniol inhibits murine skin tumorigenesis by modulating COX-2 expression, Ras-ERK1/2 signaling pathway and apoptosis. J Appl Toxicol. 2013;33(8):828–837. doi:10.1002/jat.2739
   PubMed Web of Science ®Google Scholar
• Crespo R, Montero Villegas S, Abba MC, de Bravo MG, Polo MP. Transcriptional and posttranscriptional inhibition of HMGCR and PC biosynthesis by geraniol in 2 Hep-G2 cell proliferation linked pathways. Biochem Cell Biol. 2013;91(3):131–139. doi:10.1139/bcb-2012-0076
   PubMedGoogle Scholar
• Ahmad ST, Arjumand W, Seth A, et al. Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways. Toxicology. 2011;290(1):69–81. doi:10.1016/j.tox.2011.08.020
   PubMed Web of Science ®Google Scholar
• Kim SH, Park EJ, Lee CR, et al. Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int J Oncol. 2012;40(5):1683–1690. doi:10.3892/ijo.2011.1318
   PubMed Web of Science ®Google Scholar
• Kim SH, Bae HC, Park EJ, et al. Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem Biophys Res Commun. 2011;407(1):129–134. doi:10.1016/j.bbrc.2011.02.124
   PubMed Web of Science ®Google Scholar
• Duan S, Xia Y, Tian X, et al. A multi-bioresponsive self-assembled nano drug delivery system based on hyaluronic acid and geraniol against liver cancer. Carbohydr Polym. 2023;310:120695. doi:10.1016/j.carbpol.2023.120695
   PubMed Web of Science ®Google Scholar
• Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359–362. doi:10.1038/nmeth.1322
   PubMed Web of Science ®Google Scholar
• Mitra AK, Agrahari V, Mandal A, et al. Novel delivery approaches for cancer therapeutics. J Control Release. 2015;219:248–268. doi:10.1016/j.jconrel.2015.09.067
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY. CD44-Targeted Nanocarrier for Cancer Therapy. Front Pharmacol. 2021;12:800481. doi:10.3389/fphar.2021.800481
   PubMedGoogle Scholar
• Shende P, Deshpande G. Disulfide Bond-Responsive Nanotherapeutic Systems for the Effective Payload in Cancer Therapy. Curr Pharm Des. 2020;26(41):5353–5361. doi:10.2174/1381612826666200707131006
   PubMed Web of Science ®Google Scholar
• Senbanjo LT, AlJohani H, Majumdar S, Chellaiah MA. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells. Cell Commun Signal. 2019;17(1):80. doi:10.1186/s12964-019-0395-6
   PubMedGoogle Scholar
• Feng J, Xu Z, Liu F, et al. Versatile Catalytic Deoxyribozyme Vehicles for Multimodal Imaging-Guided Efficient Gene Regulation and Photothermal Therapy. ACS Nano. 2018;12(12):12888–12901. doi:10.1021/acsnano.8b08101
   PubMed Web of Science ®Google Scholar
• Ganesh S, Iyer AK, Morrissey DV, Amiji MM. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors. Biomaterials. 2013;34(13):3489–3502. doi:10.1016/j.biomaterials.2013.01.077
   PubMed Web of Science ®Google Scholar
• Lockshin RA, Zakeri Z. Apoptosis, autophagy, and more. Int J Biochem Cell Biol. 2004;36(12):2405–2419. doi:10.1016/j.biocel.2004.04.011
   PubMed Web of Science ®Google Scholar
• Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009;16(7):966–975. doi:10.1038/cdd.2009.33
   PubMed Web of Science ®Google Scholar
• Gottlieb E, Armour SM, Harris MH, Thompson CB. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 2003;10(6):709–717. doi:10.1038/sj.cdd.4401231
   PubMed Web of Science ®Google Scholar
• Vasan K, Clutter M, Fernandez Dunne S, et al. Genes Involved in Maintaining Mitochondrial Membrane Potential Upon Electron Transport Chain Disruption. Front Cell Dev Biol. 2022;10:781558. doi:10.3389/fcell.2022.781558
   PubMed Web of Science ®Google Scholar
• Lee S, Park YR, Kim SH, et al. Geraniol suppresses prostate cancer growth through down-regulation of E2F8. Cancer Med. 2016;5(10):2899–2908. doi:10.1002/cam4.864
   PubMed Web of Science ®Google Scholar
• Okumoto K, El Shermely M, Natsui M, et al. The peroxisome counteracts oxidative stresses by suppressing catalase import via Pex14 phosphorylation. Elife. 2020;9:e55896. doi:10.7554/eLife.55896
   PubMed Web of Science ®Google Scholar
• Cipolla CM, Lodhi IJ. Peroxisomal Dysfunction in Age-Related Diseases. Trends Endocrinol Metab. 2017;28(4):297–308. doi:10.1016/j.tem.2016.12.003
   PubMed Web of Science ®Google Scholar
• Stroud DA, Surgenor EE, Formosa LE, et al. Accessory subunits are integral for assembly and function of human mitochondrial complex I. Nature. 2016;538(7623):123–126. doi:10.1038/nature19754
   PubMed Web of Science ®Google Scholar
• Emelyanova L, Preston C, Gupta A, et al. Effect of Aging on Mitochondrial Energetics in the Human Atria. J Gerontol a Biol Sci Med Sci. 2018;73(5):608–616. doi:10.1093/gerona/glx160
   PubMed Web of Science ®Google Scholar
• Reinson K, Kovacs-Nagy R, Oiglane-Shlik E, et al. Diverse phenotype in patients with complex I deficiency due to mutations in NDUFB11. Eur J Med Genet. 2019;62(11):103572. doi:10.1016/j.ejmg.2018.11.006
   PubMed Web of Science ®Google Scholar
• Walker BR, Moraes CT. Nuclear-Mitochondrial Interactions. Biomolecules. 2022;12(3):427. doi:10.3390/biom12030427
   PubMed Web of Science ®Google Scholar
• Srivastava A, Srivastava P, Mathur S, et al. Lipid Metabolism and Mitochondria: cross Talk in Cancer. Curr Drug Targets. 2022;23(6):606–627. doi:10.2174/1389450122666210824144907
   PubMed Web of Science ®Google Scholar
• Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003–2014. doi:10.3969/j.issn.1673-5374.2013.21.009
   PubMed Web of Science ®Google Scholar
• Wang C, Youle RJ. The role of mitochondria in apoptosis*. Annu Rev Genet. 2009;43:95–118. doi:10.1146/annurev-genet-102108-134850
   PubMed Web of Science ®Google Scholar
• Walker MA, Tian R. NAD(H) in mitochondrial energy transduction: implications for health and disease. Curr Opin Physiol. 2018;3:101–109. doi:10.1016/j.cophys.2018.03.011
   PubMedGoogle Scholar
• Fontanesi F, Soto IC, Barrientos A. Cytochrome c oxidase biogenesis: new levels of regulation. IUBMB Life. 2008;60(9):557–568. doi:10.1002/iub.86
   PubMed Web of Science ®Google Scholar
• Welchen E, Gonzalez DH. Cytochrome c, a hub linking energy, redox, stress and signaling pathways in mitochondria and other cell compartments. Physiol Plant. 2016;157(3):310–321. doi:10.1111/ppl.12449
   PubMed Web of Science ®Google Scholar
• Kuhlbrandt W. Structure and Mechanisms of F-Type ATP Synthases. Annu Rev Biochem. 2019;88(1):515–549. doi:10.1146/annurev-biochem-013118-110903
   PubMedGoogle Scholar
• Atlante A, Calissano P, Bobba A, Azzariti A, Marra E, Passarella S. Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death. J Biol Chem. 2000;275(47):37159–37166. doi:10.1074/jbc.M002361200
   PubMed Web of Science ®Google Scholar
• Vempati UD, Diaz F, Barrientos A, et al. Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release. Mol Cell Biol. 2007;27(5):1771–1783. doi:10.1128/MCB.00287-06
   PubMed Web of Science ®Google Scholar
• Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863(12):2977–2992. doi:10.1016/j.bbamcr.2016.09.012
   PubMed Web of Science ®Google Scholar
• Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem. 2004;73:87–106. doi:10.1146/annurev.biochem.73.011303.073706
   PubMed Web of Science ®Google Scholar
• Palma FR, He C, Danes JM, et al. Mitochondrial Superoxide Dismutase: what the Established, the Intriguing, and the Novel Reveal About a Key Cellular Redox Switch. Antioxid Redox Signal. 2020;32(10):701–714. doi:10.1089/ars.2019.7962
   PubMed Web of Science ®Google Scholar
• Bonnefoy N, Kermorgant M, Groudinsky O, Minet M, Slonimski PP, Dujardin G. Cloning of a human gene involved in cytochrome oxidase assembly by functional complementation of an oxa1- mutation in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1994;91(25):11978–11982. doi:10.1073/pnas.91.25.11978
   PubMed Web of Science ®Google Scholar